# Iberdomide Maintenance Therapy in Patients With Multiple Myeloma

> **NCT05177536** · PHASE2 · ACTIVE_NOT_RECRUITING · sponsor: **University of Nebraska** · enrollment: 40 (actual)

## Conditions studied

- Multiple Myeloma

## Interventions

- **DRUG:** Iberdomide

## Key facts

- **NCT ID:** NCT05177536
- **Lead sponsor:** University of Nebraska
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2022-04-15
- **Primary completion:** 2026-01
- **Final completion:** 2031-01
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2025-05-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05177536

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05177536, "Iberdomide Maintenance Therapy in Patients With Multiple Myeloma". Retrieved via AI Analytics 2026-07-09 from https://api.ai-analytics.org/clinical/NCT05177536. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*